Anna Roshal MD in Indianapolis, Indiana

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 1997
The Primary Medical Specialty for Anna Roshal MD is listed as: Medical Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 27
PAC (PECOS ID)#: 6901824523
NPI #: 1124081799
NPI Created On: 04/06/2006
NPI Last Updated Listed as: 10/19/2020
Primary Taxonomy Code: 207RX0202X
License Number:
2005028007
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Transfusion of blood or blood products
2. Collection of blood specimen from a completely implantable venous access device
3. Hydration infusion into a vein 31 minutes to 1 hour
4. Hydration infusion into a vein
5. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
6. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
7. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
8. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
9. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
10. Infusion of chemotherapy into a vein up to 1 hour
11. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
12. New patient office or other outpatient visit, typically 45 minutes
13. Established patient office or other outpatient visit, typically 15 minutes
14. Established patient office or other outpatient, visit typically 25 minutes
15. Established patient office or other outpatient, visit typically 25 minutes
16. Established patient office or other outpatient, visit typically 40 minutes
17. Physician telephone patient service, 11-20 minutes of medical discussion
18. Injection, dexamethasone sodium phosphate, 1 mg
19. Injection, palonosetron hcl, 25 mcg
20. Injection, pegfilgrastim, 6 mg